These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 27156131)

  • 21. Reply to Erfan Ayubi and Saeid Safiri's Letter to the Editor re: Sungmin Woo, Chong Hyun Suh, Sang Youn Kim, Jeong Yeon Cho, Seung Hyup Kim. Diagnostic Performance of Prostate Imaging Reporting and Data System Version 2 for Detection of Prostate Cancer: A Systematic Review and Diagnostic Meta-analysis. Eur Urol 2017;72:177-88.
    Woo S; Suh CH; Kim SY
    Eur Urol; 2018 Feb; 73(2):e30. PubMed ID: 28807349
    [No Abstract]   [Full Text] [Related]  

  • 22. Reply to M.V. Meng's Letter to the Editor re: H. Baumert et al. The use of polymer (Hem-o-lok) clips for management of the renal hilum during laparoscopic nephrectomy. Eur Urol 2006;49:816-9 and P.L. Steinberg et al. re: H. Baumert et al. The use of polymer (Hem-o-lok) clips for management of the renal hilum during laparoscopic nephrectomy. Eur Urol 2006;49:816-9. Eur Urol 2007;51:572-3.
    O'Kane HF; Nambirajan T
    Eur Urol; 2007 May; 51(5):1449. PubMed ID: 17229516
    [No Abstract]   [Full Text] [Related]  

  • 23. Reply to Egesta Lopci, Arturo Chiti, and Massimo Lazzeri's Letter to the Editor re: Laura Evangelista, Alberto Briganti, Stefano Fanti, et al. New Clinical Indications for
    Evangelista L; Fanti S; Picchio M
    Eur Urol; 2016 Oct; 70(4):e114-e115. PubMed ID: 27025587
    [No Abstract]   [Full Text] [Related]  

  • 24. Reply to Filippo Alongi, Rosario Mazzola, Sergio Fersino's Letter to the Editor re: Patrick C. Walsh, Nathan Lawrentschuk. Immediate Adjuvant Radiation Therapy Following Radical Prostatectomy Should Not Be Advised for Men with Extraprostatic Extension Who Have Negative Surgical Margins. Eur Urol 2016;69:191-2.
    Lawrentschuk N; Walsh PC
    Eur Urol; 2016 Dec; 70(6):e162. PubMed ID: 27240940
    [No Abstract]   [Full Text] [Related]  

  • 25. Reply to Nicola Fossati, Giorgio Gandaglia, Alberto Bossi, Francesco Montorsi, Alberto Briganti's Letter to the Editor re: Stephen J. Freedland, Voleak Choeurng, Lauren Howard, et al. Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy After Radical Prostatectomy. Eur Urol 2016;70:588-96.
    Freedland SJ; Den RB
    Eur Urol; 2016 Oct; 70(4):e110-e111. PubMed ID: 26992279
    [No Abstract]   [Full Text] [Related]  

  • 26. Reply to Yi Zhou, Weigang Yan, and Hanzhong Li's Letter to the Editor re: Eduard Baco, Erik Rud, Lars Magne Eri, et al. A Randomized Controlled Trial to Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy. Eur Urol 2016;69:149-56.
    Baco E; Rud E; Vlatkovic L
    Eur Urol; 2016 Aug; 70(2):e55. PubMed ID: 26852076
    [No Abstract]   [Full Text] [Related]  

  • 27. Reply to Michael Froehner, Rainer Koch, Manfred P. Wirth's Letter to the Editor re: Grace L. Lu-Yao, Peter C. Albertsen, Dirk F. Moore, Yong Lin, Robert S. DiPaola, Siu-Long Yao. Fifteen-year Outcomes Following Conservative Management Among Men Aged 65 Years or Older with Localized Prostate Cancer. Eur Urol 2015;68:805-11.
    Albertsen PC; Lu-Yao GL
    Eur Urol; 2016 Jun; 69(6):e131-2. PubMed ID: 26706104
    [No Abstract]   [Full Text] [Related]  

  • 28. Reply to Emmanuele A. Jannini's Words of wisdom re: the role of short frenulum and the effects of frenulectomy on premature ejaculation [J Sex Med 2010;7:1269-76]. Eur Urol 2010;57:1119-20.
    Gallo L; Perdonà S; Gallo A
    Eur Urol; 2010 Oct; 58(4):e49-50. PubMed ID: 20705388
    [No Abstract]   [Full Text] [Related]  

  • 29. Re: Scott P. Kelly, Philip S. Rosenberg, William F. Anderson, et al. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race. Eur Urol 2017;71:195-201.
    Brookman-May SD; May M; Lebentrau S; Klotz T
    Eur Urol; 2017 May; 71(5):e145-e146. PubMed ID: 28008855
    [No Abstract]   [Full Text] [Related]  

  • 30. Reply to Giandomenico Roviello, Daniele Generali, and Roberto Petrioli's Letter to the Editor re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033.
    de Bono JS
    Eur Urol; 2017 Feb; 71(2):e56. PubMed ID: 27544577
    [No Abstract]   [Full Text] [Related]  

  • 31. Letter to the Editor; Re: Wirth MP, Weissbach L, Marx F-J, Heckl W, Jellinghaus W, Riedmiller H, Noack B, Hinke A, Froehner M. Prospective randomized trial comparing flutamide as adjuvant treatment versus observation after radical prostatectomy for locally advanced, lymph node-negative prostate cancer. Eur Urol 2004;45:267-70.
    Rocco B; Matei DV; de Cobelli O; Rocco F
    Eur Urol; 2004 Aug; 46(2):272-3; author reply 273. PubMed ID: 15245825
    [No Abstract]   [Full Text] [Related]  

  • 32. Re: Rachel M. Glicksman, Ur Metser, Douglass Vines, et al. Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis. Eur Urol 2021;80:374-82.
    Liu W; Zukotynski K; Bauman G
    Eur Urol; 2021 Sep; 80(3):e77-e78. PubMed ID: 34130872
    [No Abstract]   [Full Text] [Related]  

  • 33. Reply to Vincenza Conteduca, Cristian Lolli, and Ugo De Giorgi's Letter to the Editor re: Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol 2016;70:724-31.
    Rescigno P; de Bono JS
    Eur Urol; 2016 Dec; 70(6):e170-e171. PubMed ID: 27240941
    [No Abstract]   [Full Text] [Related]  

  • 34. Reply to Salvador Vale's Letter to the Editor re: Cesare Cozzarini. Whole-pelvis Radiotherapy in the Radiation Treatment of Intermediate- and High-risk Prostate Cancer: How to Improve the Therapeutic Ratio of a Potentially Effective but still Unsatisfactory Treatment? Eur Urol 2017;71:44-5. Preclinical Combinatory Approach to Enhance Radiotherapy Effects and Reduce its Morbidity may be Tested in the Clinic: Wider Whole-pelvis Radiotherapy Fields and Enhanced Antitumoral Effect Mediated by T Lymphocytes: A Legitimate Hypothesis?
    Cozzarini C; Benigni F; Fiorino C; Mondino A; Di Muzio N
    Eur Urol; 2017 Aug; 72(2):e34-e35. PubMed ID: 28214033
    [No Abstract]   [Full Text] [Related]  

  • 35. Re: François Giuliano, Donald L. Patrick, Hartmut Porst, et Al. for the 3004 study group. Premature ejaculation: results from a five-country European observational study. Eur urol 2008;53:1048-57.
    Waldinger MD; Schweitzer DH
    Eur Urol; 2008 Jun; 53(6):1304-5; author reply 1305-6. PubMed ID: 18262333
    [No Abstract]   [Full Text] [Related]  

  • 36. Reply to Eugenio Ventimiglia, Francesco Montorsi, and Andrea Salonia's Letter to the Editor re: Jakob Damsgaard, Ulla N. Joensen, Elisabeth Carlsen, et al. Varicocele Is Associated with Impaired Semen Quality and Reproductive Hormone Levels: A Study of 7035 Healthy Young Men from Six European Countries. Eur Urol 2016;70:1019-29.
    Damsgaard J; Joensen UN; Carlsen E; Erenpreiss J; Jensen MB; Matulevicius V; Zilaitiene B; Olesen IA; Perheentupa A; Punab M; Salzbrunn A; Toppari J; Virtanen HE; Juul A; Skakkebæk NE; Jørgensen N
    Eur Urol; 2017 Feb; 71(2):e71-e72. PubMed ID: 27638092
    [No Abstract]   [Full Text] [Related]  

  • 37. Frequency of ejaculation and risk of prostate cancer.
    Giles GG; Severi G; English DR; Hopper JL
    JAMA; 2004 Jul; 292(3):329; author reply 329. PubMed ID: 15265846
    [No Abstract]   [Full Text] [Related]  

  • 38. Re: Michael J. Morris, Daisy Huang, William K. Kelly, et al. Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate. Eur Urol 2009;56:237-44.
    Drewa T; Chlosta P
    Eur Urol; 2010 Feb; 57(2):e18-9; author reply e20. PubMed ID: 19853990
    [No Abstract]   [Full Text] [Related]  

  • 39. Re: See W, Iversen P, Wirth M, McLeod D, Garside L, Morris T. Immediate treatment with bicalutamide 150 mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostatic cancer. Eur Urol 2003;44:512-8.
    Tubaro A; De Nunzio C
    Eur Urol; 2004 May; 45(5):674; author reply 674-5. PubMed ID: 15082213
    [No Abstract]   [Full Text] [Related]  

  • 40. Reply from Authors re: Goutham Vemana, Gerald L. Andriole. Bad Habits May Be Hard to Break. Eur Urol 2013;63:426-7: Changing Habits.
    Nordström T; Clements MS; Adolfsson J; Grönberg H
    Eur Urol; 2013 Mar; 63(3):427. PubMed ID: 23265389
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.